CARDIOME PHARMA (NASDAQ:CRME)
3.73
+0.04 (1.08%)
| CARDIOME PHARMA (NASDAQ:CRME) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $3.69 | 52 Week High | $6.70 | ||
| Open | $3.70 | 52 Week Low | $2.57 | ||
| Day High | $3.75 | P/E | N/A | ||
| Day Low | $3.65 | EPS | $0.00 | ||
| Volume | 142,720 | ||||
| More CRME Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| COM | 9 | MRK | 5 |
| GYMB | 2 | ANF | 2 |
| APWR | 2 | TXT | 2 |
| MTRX | 2 | BAC | 2 |
| WFC | 2 | EQY | 2 |
| EXM | 1 | CLNE | 1 |
Entities who have mentioned CRME
- JPMorgan | View Related Stories »
- Dividend | View Related Stories »
- Citi | View Related Stories »
- Merrill Lynch | View Related Stories »
- UBS | View Related Stories »
- SAC Capital | View Related Stories »
- Steven A. Cohen | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- Bakken Formation | View Related Stories »
- Bear Stearns | View Related Stories »
- Lehman Brothers | View Related Stories »
- Carl Icahn | View Related Stories »
- RBC Capital | View Related Stories »
- Banc of America | View Related Stories »
- Barclays | View Related Stories »
- CVC Capital Partners | View Related Stories »
- Treasury Capital Purchase Program | View Related Stories »
- Unusual 11 Mid-Day Movers | View Related Stories »
- Hellman & Friedman LLC | View Related Stories »
- Thomas Weisel Partners Group | View Related Stories »
- Deutsche Bank | View Related Stories »
- Bankruptcy | View Related Stories »
- Goldman Sachs | View Related Stories »
- Stock Buyback | View Related Stories »
- After-Hours Movers | View Related Stories »
View All Major News StreetInsider.com Major News for CRME
- Cardiome Pharma (CRME) Reports a Q1 Loss
- Cardiome Pharma (CRME) Reports Smaller-Than-Expected Q2 Loss
- Cardiome Pharma (CRME) Appoints Doug Janzen as CEO
View All ReportsStreetInsider.com Reports on CRME
- Cardiome Pharma (CRME) Reports a Q1 Loss
- Cardiome Pharma (CRME) Extends "Dutch Auction" Tender Offer
- Cardiome Pharma (CRME) Commences $27.5M Tender Offer
- After-Hours Movers 8/25: DDSS, CRME, MYGN, BCSI Higher; HAIN Lower
- Cardiome Pharma (CRME) Announces Tender Offer To Purchase Up To US$27.5 Million Of Its Common Shares
View All Press ReleasesCompany Press Releases on CRME
- Cardiome Reports Third Quarter Results
- Cardiome to Release Third Quarter Results
- Cardiome To Present At Oppenheimer Healthcare Conference
- Cardiome And Astellas Announce Initiation Of Patient Enrolment In ACT 5 Trial
- Cardiome Pharma Corp. Announces Final Results of Tender Offer
StreetInsider Reports on CRME by Category
View All BlogsBlogs on CRME
- Closing Update for Wednesday, August 26: Scrapping Back
- Analyst upgrades, downgrades and initiations: ALL, CMG, GRMN, IP, VRSN ...
- Cash for Cardiovascular: Who Might Be Next?
- Cardiome May See More Upside When IV Formulation Gets Clarified - RBC
- How Will Cardiome, Merck, Eli Lilly, and Par Pharma's Phase 3 Trials Perform?
View All FilingsSEC Filings on CRME
- Form 6-K Cardiome Pharma Corp For: Sep 30
- Form 6-K Cardiome Pharma Corp For: Nov 09
- Form 6-K Cardiome Pharma Corp For: Oct 28
- Form 6-K Cardiome Pharma Corp For: Oct 16
- Form 6-K Cardiome Pharma Corp For: Oct 14
Comments on recent CRME articles
Comments on CRME
No comments are currently available.
on Apr 16, 2009
at 12:53 PM what sky rocket Not one of tour quotes is even close to what they are trading. whos street are you on.
Article: Unusual 11 Mid-Day Movers 4/9: TXT, APWR, BAC, CRME Higher; FAZ, HPT, MTRX, ANF Lower